RxDoctor Payments Data

Kimberly Bouvette, MD

Physical Medicine & Rehabilitation · Oklahoma City, OKNPI 1790717692

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 33 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Pfizer accounts for 67.3% of it on its own, with 6 other manufacturers making up the rest.

$613in general payments, 2019–2025

Across 33 payments — averaging $18.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$412
  • AbbVie$80
  • Amneal Pharmaceuticals LLC$39
  • ANI Pharmaceuticals, Inc.$28
  • Vertex$26
  • Coloplast$17
  • plus $12 from 1 others

What the payments were for

  • Food & beverage$613100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$613 in reported general payments places this provider in the 80th percentile of 51 physical medicine & rehabilitation providers in Oklahoma.

See all physical medicine & rehabilitation providers in Oklahoma

Medicare billing

Part B allowed, 2024
$267,186
Medicare patients
448
Services billed
3,513

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban26$12,566
Baclofen19$1,396
Duloxetine Hcl13$1,061
Pregabalin36$755
Tizanidine Hcl29$520
Gabapentin26$466
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen40$327
Pantoprazole Sodium39$306
Hydralazine Hcl29$241
Potassium Chloride27$218
Atorvastatin Calcium40$210
Metoprolol Tartrate46$186
Levetiracetam11$180
Losartan Potassium29$175
Oxycodone Hcl38$174

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$412$12,56626 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 51 physical medicine & rehabilitation providers in Oklahoma.

Other physical medicine & rehabilitation in Oklahoma City

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →